白血病患者细菌感染诊断和治疗策略

[1]	中华医学会血液学分会,中国医师协会血液科医师分会.中国中性粒细胞缺乏伴发热患者抗菌药物临床应用指南[J].中华血液学杂志,2012,33(8):693-696.
[2]	叶芳,贾宁,何玉梅,等.1741例血液病患者中721株病原菌感染临床分析[J].临床医药实践,2011,20(4):243-244.
[3]	孙景勇,倪语星.血液病房细菌耐药监测[J].中华医院感染学杂志,2006,16(2):206-208,217.
[4]	邓琦,李新,李静怡,等.血液系统疾病医院感染临床分离菌株分布与耐药性分析[J].中华医院感染学杂志,2009,19(9):1159-1162.
[5]	韩婷婷,黄晓军,刘开彦,等.造血干细胞移植患者粒细胞缺乏期间血流感染的单中心临床分析[J].中华内科杂志,2011,50(8):654-658.
[6]	朱骏,丁星,王椿,等.血液系统疾病患者中临床分离菌分布及耐药性分析[J].中国感染与化疗杂志,2006,6(1):37-41.
[7]	王秀丽,吴德沛,孙爱宁,等.血液病医院感染病原菌特点及利奈唑胺在粒细胞缺乏感染治疗中的应用[J].中华医院感染学杂志,2010,20(11):1589-1591.
[8]	李春艳.血液病房感染病原菌分布及耐药性分析[J].中华医院感染学杂志,2008,18(8):1179-1182.
[9]	Averbuch P,Orasch C,Cordonnier C,et al.European guideline for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance:summary of the 20114th European Conference on Infections in Leukemia[J].Haematologica,2013,98:1826-1835.
[10]	Freifeld AG,Bow EJ,Sepkowitz KA,et al.Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer:2010 update by the infectious diseases society of America[J].Clin Infect Dis,2011,52:e56-e93.
[11]	Paul M,Yahav D,Fraser A,et al.Empirical antibiotic monotherapy for febrile neutropenia:systematic review and meta-analysis of randomized controlled trials[J].J Antimicrob Chemother,2006,57:176-189.
[12]	Kang CI,Kim SH,Park WB,et al.Bloodstream infections caused by antibiotic-resistant gram-negative bacilli:risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome[J].Antimicrob Agents Chemother,2005,49:760-766.
[13]	Lodise TP Jr,Patel N,Kwa A,et al.Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections:impact of delayed appropriate antibiotic selection[J].Antimicrob Agents Chemother,2007,51:3510-3515.
[14]	American Thoracic Society,Infectious Diseases Society of America.Guidelines for the management of adults with hospital-acquired,ventilator-associated,and healthcare-associated pneumonia[J].Am J Respir Crit Care Med,2005,171:388-416.